KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme (CME) Change in Account Payables (2016 - 2025)

Cme (CME) has disclosed Change in Account Payables for 17 consecutive years, with -$3.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Account Payables rose 93.8% to -$3.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$8.1 million, a 24.3% increase, with the full-year FY2025 number at -$8.1 million, up 24.3% from a year prior.
  • Change in Account Payables was -$3.1 million for Q4 2025 at Cme, up from -$17.5 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $36.7 million in Q4 2023 to a low of -$50.0 million in Q4 2024.
  • A 5-year average of $226315.8 and a median of -$3.1 million in 2025 define the central range for Change in Account Payables.
  • Biggest YoY gain for Change in Account Payables was 934.48% in 2024; the steepest drop was 236.24% in 2024.
  • Cme's Change in Account Payables stood at -$22.2 million in 2021, then soared by 218.47% to $26.3 million in 2022, then surged by 39.54% to $36.7 million in 2023, then tumbled by 236.24% to -$50.0 million in 2024, then soared by 93.8% to -$3.1 million in 2025.
  • Per Business Quant, the three most recent readings for CME's Change in Account Payables are -$3.1 million (Q4 2025), -$17.5 million (Q3 2025), and -$7.8 million (Q2 2025).